BSENovelix Pharmaceuticals Ltd· Healthcare ServicesHighNeutral
Announced Thu, 9 Jul, 2026 · 19:27 IST

Warrant conversion plus preferential share allotment approved

Warrants ConvertedFund Raising View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.7%Reaction day
₹66.03
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.4%-0.7% vs market
Healthcare Services peers, median of 58sector · industry level+0.6%+0.1% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.1 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.7+1.4-0.7+0.6+0.1
Next day
+2.2+1.5+0.6+0.7+1.4
2d
+6.9+0.5+6.4+0.2+6.8
3d
+7.5+1.1+6.4+0.6+7.0
4d
+0.7+0.7+0.1-0.1+0.8
5d
+1.5-0.4+1.9-1.3+2.8
1w
+5.6+0.5+5.1-0.5+6.1
15d
+6.5+0.1+6.4-1.1+7.5
1m
+11.1+3.5+7.6+0.3+10.8
2m
+17.5+5.8+11.7+0.8+16.7
3m
-2.3+2.4-4.7-7.5+5.2
UpDownMarket · Nifty Microcap 250Sector · Healthcare Services peers, median of 58Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved allotment of 33.75 lakh shares at Rs 20 each (Rs 10 premium) on conversion of warrants by promoter group, receiving Rs 5.06 crore. Also allotted 12 lakh shares at Rs 57 each (Rs 47 premium) to 15 non-promoter investors via preferential issue, raising Rs 6.84 crore. Paid-up capital rises from Rs 23.90 crore to Rs 28.47 crore.

Likely market impact

Share count rises 19% via new allotments. Promoter group holding grows through warrant conversion; non-promoter investor base widens.